Dexrazoxane Intravenous and Empagliflozin and Metformin Extended-Release Tablets
Determining the interaction of Dexrazoxane Intravenous and Empagliflozin and Metformin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: empagliflozin / metformin
Brand name: Synjardy, Synjardy XR
Synonyms: Empagliflozin and metformin, Empagliflozin and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Empagliflozin and Metformin Tablets
- Dexrazoxane Intravenous-Empliciti
- Dexrazoxane Intravenous-Emsam
- Dexrazoxane Intravenous-Emsam Transdermal
- Dexrazoxane Intravenous-Emtricitabine
- Dexrazoxane Intravenous-Emtricitabine and tenofovir
- Empagliflozin and Metformin Extended-Release Tablets-Dextenza Insert
- Empagliflozin and Metformin Extended-Release Tablets-Dextenza intraocular
- Empagliflozin and Metformin Extended-Release Tablets-Dextran 40
- Empagliflozin and Metformin Extended-Release Tablets-Dextran 70 6% in 5% Dextrose high molecular weight
- Empagliflozin and Metformin Extended-Release Tablets-Dextran 75
- Empagliflozin and Metformin Extended-Release Tablets-Dextran high molecular weight